ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Slowing the Rise of Oropharyngeal Cancers

by Mary Beth Nierengarten • August 1, 2013

  • Tweet
  • Email
Print-Friendly Version

You Might Also Like

  • COSM14: HPV Status and Prognosis for Oropharyngeal Cancers
  • HPV Related to Rise in Head and Neck Cancers
  • Tests Emerging as Standards for Diagnosing HPV-Positive Oropharyngeal Cancer
  • Transoral Robotic Surgery Newest Treatment Option for Oropharyngeal Cancers
Explore This Issue
August 2013

HPV Vaccination Rates

  • 32% of girls between the ages of 13 and 17 have completed the recommended three-dose HPV vaccine.
  • 49% of girls received at least one dose of the vaccine.
  • 8.3% of boys received at least one dose of the vaccine.

Recommendations for the HPV Vaccine

    Who should receive the vaccine?

    Girls:

    • Routine vaccination of girls aged 11 to 12 years
    • Vaccination for unvaccinated girls and women aged 13-26 years

    Boys:

    • Routine vaccination of boys aged 11 to 12 years
    • Vaccination for unvaccinated boys and men aged 13-21

    What vaccines are available?

    • Cervarix: Licensed for girls
    • Gardasil: Licensed for girls and boys

With the availability of a simple and safe vaccine with proven efficacy to prevent cervical and, it is widely thought, human papillomavirus-related oropharyngeal cancers, why aren’t more people demanding it and more providers recommending it? This question takes on new importance in light of the results of a recent national survey that concluded that the rates of adolescents receiving the HPV vaccine remain low since its initial approval for girls in 2006 and for boys in 2011 for prevention of HPV-related cancers.

Data from the National Immunization Survey-Teen (NIS-Teen) found that only 32 percent of girls between the ages of 13 and 17 have completed the recommended three-dose HPV vaccine, and only 49 percent of girls received at least one dose of the vaccine. For boys, the uptake was substantially lower, with only 8.3 percent of boys receiving at least one dose and no available data on those receiving the full three doses (MMWR Morb Mortal Wkly Rep. 2012;61:671-677). For older girls and women the uptake is also low, with data from a 2010 National Health Interview Survey showing that only one in eight women aged 18 to 26 years completed the three-dose regimen (Cancer. 2013;119:1386-1392).

The importance of increasing the uptake of HPV vaccination is highlighted by recent data that show its robust efficacy. Data published this spring showed that the vaccine decreased the rates of infection with HPV strains covered by the vaccine by 56 percent in 14- to 19-year old girls in the first four years following the vaccine’s availability, when compared with the four years prior to the vaccine’s availability (J Infect Dis. 2013; doi: 10.1093/infdis/jit192). Decreasing HPV infection through vaccination is considered critical to the reduction and prevention of specific cancers, with HPV infection considered the cause of most, if not all, cervical cancers, 90 percent of anal cancers, and 40 percent of vaginal, vulvar and penile cancers. In addition, HPV infection is reported to be linked to more than 50 percent of oropharyngeal cancers (J Natl Cancer Inst. 2013;105:175-201).

Pages: 1 2 3 4 5 | Single Page

Filed Under: Features, Head and Neck, Laryngology, Pediatric, Practice Focus Tagged With: adolescents, cancer, HPV, Oropharyngeal, vaccineIssue: August 2013

You Might Also Like:

  • COSM14: HPV Status and Prognosis for Oropharyngeal Cancers
  • HPV Related to Rise in Head and Neck Cancers
  • Tests Emerging as Standards for Diagnosing HPV-Positive Oropharyngeal Cancer
  • Transoral Robotic Surgery Newest Treatment Option for Oropharyngeal Cancers

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Weaning Patients Off of PPIs
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.